Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accelerated Technologies, Inc. (ATI) was a medical device company and incubator focused on developing innovative solutions for cardiovascular disease management. The company's primary achievement was the development of the HeartPod, a miniaturized, implantable sensor designed to monitor left atrial pressure in patients with chronic heart failure. This technology enabled remote hemodynamic monitoring, allowing physicians to adjust therapy proactively based on real-time physiological data. ATI was acquired by Medtronic in 2007 to bolster its portfolio in heart failure management and remote patient monitoring technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accelerated Technologies.